Table 2.

Association of OLFM4, ERα and PR expression detected by IHC with clinico-pathological features of endometrioid adenocarcinoma

	OLFM4 expression			ERα expression			PR expression
Parameters	High	Low	P	High	Low	P	High	Low	P
Age
<60 (n = 140)	103	37	0.010	70	70	0.051	102	38	0.004
≥60 (n = 60)	33	27		21	39		31	29
Menostasia
No (n = 91)	66	25	0.210	47	44	0.111	69	22	0.011
Yes (n = 109)	70	39		44	65		64	45
FIGO stages
I (n = 147)	107	40	0.016	75	72	0.009	109	38	<0.001
II–IV (n = 53)	29	24		16	37		24	29
Histological grade
Well (n = 86)	70	16	<0.001	63	23	<0.001	73	13	<0.001
Moderate(n = 84)	55	29		25	59		52	32
Poor (n = 30)	11	19		3	27		8	22
Myometrial invasion
<1/2 (n = 143)	105	38	0.009	74	69	0.005	102	41	0.022
≥1/2 (n = 57)	31	26		17	40		31	26
Lymph node metastasis
No (n = 182)	125	57	0.511	88	94	0.010	129	53	<0.001
Yes (n = 18)	11	7		3	15		4	14